Intel Corporation et al. v. Telefonaktiebolaget LM Ericsson

IPR2024-01009

Intel and others challenged Ericsson's '659 Patent, arguing that its deblocking filter equations are obvious over prior art references like Fu and Bjontegaard. The petition asserts that a Person Having Ordinary Skill in the Art would have routinely optimized the claimed coefficients using existing knowledge of high-pass filters.

Jurisdiction
US PTAB
Case Number
IPR2024-01009
Decision Date
14 June 2024
Filing Date
14 June 2024

Detailed Summary

This IPR challenges Telefonaktiebolaget LM Ericsson's '659 Patent, which relates to deblocking filters used in video compression. The petitioner, Intel Corporation et al., asserts that the claims are rendered obvious under 35 U.S.C. § 103. Specifically, they argue that the claimed modifications and filter coefficients are merely routine optimizations derivable from prior art references such as Fu, Bjontegaard, List, and JCTVC-B205. The petition details how a Person Having Ordinary Skill in the Art (POSITA) would have easily arrived at the claimed structure through standard experimentation or mathematical equivalence.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Intel Corporation et al. vs Telefonaktiebolaget LM Ericsson is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-00893

Sun Pharmaceutical Industries, Inc.vsNivagen Pharmaceuticals, Inc.

Sun Pharmaceutical filed a Director Review request in IPR2025-00893 concerning patent 11878076 owned by Nivagen Pharmaceuticals. The Patent Owner may file a limited response within five business days, and no new evidence is allowed.

patentIPR2024-01312

Biofrontera Incorporated et al.vsSun Pharmaceutical Industries, Inc.

The PTAB found all challenged claims unpatentable by a preponderance of the evidence. The Petitioner successfully argued that combining prior art references (Lundahl and Larsen) rendered the illuminator system obvious to a Person Having Ordinary Skill in the Art (POSITA).

patentIPR2025-01025

Imperative Care, Inc.vsInari Medical, Inc. et al.

The PTAB institution decision in this IPR found that the petitioner met its burden of showing a reasonable likelihood of prevailing on at least claim 1. The dispute centers on obviousness (35 U.S.C. § 103) regarding medical devices used for aspirating clot material from blood vessels.

patentIPR2025-01057

Ascentcare Dental Products, Inc.vsSolmetex, LLC

Dr. Brian P. Black submits a declaration supporting Ascentcare’s IPR petition, asserting that the ’969 dental isolation mouthpiece patent is anticipated or obvious over multiple prior art references. He targets claims 1‑4 and 6‑19, concluding they are unpatentable.

patentIPR2025-01461

ToughBuilt Industries, Inc.vsMeridian International Co. Ltd.

ToughBuilt Industries petitions the PTAB to invalidate Meridian International’s 11,192,689 patent covering a stackable storage system with a sliding latch. The petition alleges anticipation and obviousness over multiple prior‑art references, seeking cancellation of all 20 claims.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call